Q3 2024 |
51 |
$293M |
+$92M |
-$117M |
-$24.9M |
SRPT, NVO, BPMC, AXSM, TARS
|
13F-HR |
11/14/2024, 09:13 AM |
Q2 2024 |
59 |
$287M |
+$97.4M |
-$100M |
-$2.82M |
BHVN, MLTX, SLNO, AXSM, ASND
|
13F-HR |
8/14/2024, 11:40 AM |
Q1 2024 |
63 |
$308M |
+$164M |
-$42M |
+$122M |
AXSM, SRPT, BHVN, MLTX, ROIV
|
13F-HR |
5/15/2024, 09:18 AM |
Q4 2023 |
44 |
$174M |
+$78M |
-$143M |
-$65.1M |
AXSM, BHVN, SRPT, AMAM, ROIV
|
13F-HR |
2/14/2024, 08:13 AM |
Q3 2023 |
83 |
$304M |
+$145M |
-$98.3M |
+$46.9M |
XBI, MLTX, SRPT, MLTX, AKRO
|
13F-HR |
11/14/2023, 08:44 AM |
Q2 2023 |
73 |
$303M |
+$70.3M |
-$125M |
-$54.9M |
XBI, TGTX, MLTX, AKRO, APLS
|
13F-HR |
8/14/2023, 09:30 AM |
Q1 2023 |
58 |
$338M |
+$194M |
-$70.6M |
+$124M |
RETA, XBI, SRPT, TGTX, AMLX
|
13F-HR |
5/15/2023, 08:42 AM |
Q4 2022 |
35 |
$234M |
+$60.2M |
-$64.2M |
-$4M |
RETA, AXSM, ASND, APLS, QQQ
|
13F-HR |
2/14/2023, 07:44 AM |
Q3 2022 |
42 |
$349M |
+$171M |
-$24.1M |
+$147M |
XBI, APLS, RLMD, RETA, RLMD
|
13F-HR |
11/14/2022, 07:33 AM |
Q2 2022 |
33 |
$192M |
+$83.3M |
-$44.5M |
+$38.8M |
XBI, CLDX, FOLD, APLS, SRPT
|
13F-HR |
8/15/2022, 12:08 PM |
Q1 2022 |
42 |
$461M |
+$297M |
-$39.8M |
+$257M |
SPY, XBI, ASND, COGT, APLS
|
13F-HR |
5/16/2022, 08:05 AM |
Q4 2021 |
46 |
$279M |
+$101M |
-$50.6M |
+$50M |
ASND, APLS, COGT, CLDX, RAPT
|
13F-HR |
2/16/2022, 11:37 AM |
Q3 2021 |
55 |
$303M |
+$86.6M |
-$108M |
-$21.4M |
ASND, IOVA, CLDX, COGT, ARVN
|
13F-HR |
11/15/2021, 11:34 AM |
Q2 2021 |
49 |
$320M |
+$69.4M |
-$90.4M |
-$21M |
RAPT, ASND, FATE, XENE, ARVN
|
13F-HR |
8/10/2021, 06:54 PM |
Q1 2021 |
46 |
$357M |
+$88.7M |
-$86.8M |
+$1.9M |
SNDX, ASND, KURA, IOVA, FATE
|
Restatement |
8/10/2021, 06:44 PM |
Q4 2020 |
43 |
$449M |
+$167M |
-$59.6M |
+$108M |
QQQ, SNDX, RCKT, IOVA, APLS
|
Restatement |
2/17/2021, 05:29 PM |
Q3 2020 |
46 |
$346M |
+$111M |
-$37.6M |
+$73.7M |
XBI, ASND, MRSN, IOVA, IMVT
|
13F-HR |
11/16/2020, 05:18 AM |
Q2 2020 |
43 |
$379M |
+$83.4M |
-$207M |
-$123M |
XBI, IMMU, SPY, CNST, ADVM
|
13F-HR |
8/14/2020, 07:14 AM |
Q1 2020 |
47 |
$377M |
+$130M |
-$59.9M |
+$70.3M |
XBI, SPY, QQQ, XLV, CNST
|
13F-HR |
5/15/2020, 08:25 AM |
Q4 2019 |
52 |
$525M |
+$239M |
-$148M |
+$90.5M |
SPY, XBI, ASND, CNST, AXSM
|
Restatement |
4/9/2020, 01:16 PM |
Q3 2019 |
44 |
$393M |
+$156M |
-$78.4M |
+$77.9M |
XBI, SPY, BPMC, MRTX, SRPT
|
Restatement |
4/9/2020, 01:03 PM |
Q2 2019 |
43 |
$482M |
+$251M |
-$77.9M |
+$173M |
SRPT, XBI, QQQ, BPMC, MRTX
|
Restatement |
4/9/2020, 01:01 PM |
Q1 2019 |
39 |
$383M |
+$205M |
-$35.8M |
+$169M |
ASND, ACAD, ASND, BPMC, FOLD
|
Restatement |
4/9/2020, 12:58 PM |
Q4 2018 |
40 |
$276M |
+$140M |
-$51.4M |
+$88.3M |
XBI, MRTX, DRNA, VRTX, IMMU
|
Restatement |
4/8/2020, 08:10 PM |
Q3 2018 |
54 |
$470M |
+$224M |
-$43.4M |
+$180M |
XBI, SRPT, PTCT, MRTX, ECYT
|
Restatement |
4/8/2020, 08:17 PM |
Q2 2018 |
44 |
$339M |
+$145M |
-$81M |
+$64.2M |
IMMU, MRTX, SRPT, PTCT, ALNY
|
13F-HR |
8/14/2018, 09:07 AM |
Q1 2018 |
52 |
$494M |
+$326M |
-$3.4B |
-$3.08B |
INCY, XBI, IMMU, ECYT, SRPT
|
13F-HR |
5/15/2018, 09:03 AM |
Q4 2017 |
49 |
$426M |
+$235M |
-$64.8M |
+$171M |
XBI, IMMU, IMMU, ARGX, CELG
|
13F-HR |
2/14/2018, 08:00 AM |
Q3 2017 |
63 |
$471M |
+$235M |
-$67.8M |
+$167M |
XBI, IMMU, ZGNX, ZGNX, AVXS
|
13F-HR |
11/14/2017, 09:00 AM |
Q2 2017 |
66 |
$481M |
+$239M |
-$136M |
+$103M |
CLVSQ, XBI, PTLA, BMY, AVXS
|
13F-HR |
8/14/2017, 09:40 AM |
Q1 2017 |
64 |
$537M |
+$298M |
-$43.1M |
+$255M |
XBI, IWM, SPY, DBVT, AVXS
|
13F-HR |
5/15/2017, 08:53 AM |
Q4 2016 |
70 |
$415M |
+$164M |
-$72.9M |
+$91.5M |
XBI, SHPG, ABT, ALXN, ZBH
|
13F-HR |
2/14/2017, 02:02 PM |
Q3 2016 |
87 |
$612M |
+$352M |
-$59.5M |
+$293M |
XBI, IBB, IWM, SRPT, SRPT
|
13F-HR |
11/14/2016, 08:47 AM |
Q2 2016 |
63 |
$346M |
+$264M |
-$13.2M |
+$251M |
IWM, XBI, SPY, GWPH, OPHT
|
13F-HR |
8/12/2016, 02:01 PM |
Q1 2016 |
49 |
$173M |
+$119M |
-$42.9M |
+$76.5M |
XBI, ACAD, CELG, EW, BSX
|
Restatement |
5/16/2016, 05:15 PM |
Q4 2015 |
46 |
$239M |
+$146M |
-$24M |
+$122M |
NUVA, AMGN, WMGI, PTLA, SAGE
|
Restatement |
2/17/2016, 01:54 PM |
Q3 2015 |
73 |
$221M |
+$131M |
-$39.4M |
+$91.3M |
AGN, NUVA, FPRX, MNKKQ, ZLTQ
|
13F-HR |
11/16/2015, 11:40 AM |
Q2 2015 |
69 |
$309M |
+$211M |
-$22.3M |
+$189M |
AGN, FLML, BIIB, NUVA, ALNY
|
Restatement |
9/9/2015, 03:04 PM |
Q1 2015 |
62 |
$270M |
+$178M |
-$13.4M |
+$164M |
XBI, ZBH, B108PS, CYH, NUVA
|
Restatement |
5/15/2015, 04:26 PM |
Q4 2014 |
59 |
$207M |
+$148M |
-$12.2M |
+$136M |
GILD, ZBH, SYK, ISIS, AAVL
|
Restatement |
2/17/2015, 06:32 PM |
Q3 2014 |
69 |
$181M |
+$138M |
-$13.4M |
+$124M |
CYH, HZNPXXXX, ZBH, TRNX, VRTX
|
13F-HR |
11/14/2014, 03:22 PM |
Q2 2014 |
54 |
$142M |
+$102M |
-$12.8M |
+$89.2M |
B108PS, MDVN, COO, TEVA, BSX
|
13F-HR |
8/14/2014, 04:09 PM |
Q1 2014 |
64 |
$165M |
+$104M |
-$19.1M |
+$85M |
PRTA, BMY, FLML, ARAY, AMAG
|
13F-HR |
5/15/2014, 04:10 PM |
Q4 2013 |
62 |
$163M |
|
|
|
GILD, BMY, BIIB, SPNC, ARAY
|
Restatement |
4/30/2014, 05:56 PM |